One of several solutions lies with clinical summaries that access and synthesise systematic reviews of evidence that address focused clinical problems. Indeed there is now an established hierarchy of pre-appraised synthesised evidence that enables more efficient access to clinically relevant information. The base of this information pyramid is the individual original studies. It then moves to ever-increasing synthesised evidence: synopses of studies, (evidencebased medicine, ACP journal club); synthesis (The Cochrane Library); synopses of synthesis (DynaMed); summaries (National Clinical Guidelines, Clinical Evidence), and ends up with point-of-care decision support, a final 'systems' layer. 4 The Cochrane Collaboration, and the explicit, systematic, and transparent methods that are used, are prime movers in the information revolution that enables safer patient care. Let us not forget that it is Cochrane authors who have shown how the research agenda can be misled at the inception, funding, publication, and reporting stages. 5 We do not have to look far for examples of drugs that had disastrous consequences for some patients (rosiglitazone and rofecoxib); and other drugs that have questionable clinical benefit (gabapentin and oseltamivir). 5 While sometimes 'boring', Cochrane reviews are seldom irrelevant. A recent example of a Cochrane review that has important clinical and policy implications concerns the use of general health checks in adults, shown not to reduce morbidity and mortality, despite the fact that the UK government began a policy of health checks for adults in 2009. 6 We urge readers to take a more critical view of the medical literature and its relevance to their clinical practice. Cochrane reviews remain key components for GPs who wish to remain safe and effective doctors.
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